The SHARE road map:Healthgrids for biomedical research and healthcare by Andoulsi, I. et al.
RESEARCH OUTPUTS / RÉSULTATS DE RECHERCHE
Author(s) - Auteur(s) :
Publication date - Date de publication :
Permanent link - Permalien :
Rights / License - Licence de droit d’auteur :
Bibliothèque Universitaire Moretus Plantin
Institutional Repository - Research Portal
Dépôt Institutionnel - Portail de la Recherche
researchportal.unamur.beUniversity of Namur
The SHARE road map
Andoulsi, I.; Blanquer, I.; Breton, V.; Dobrev, A.; Van Doosselaere, C.; Hernandez, V.;
Herveg, J.; Jacq, N.; Legré, Y.; Olive, M.; Rahmouni, H.; Solomonides, T.; Stroetmann, K.;






Publisher's PDF, also known as Version of record
Link to publication
Citation for pulished version (HARVARD):
Andoulsi, I, Blanquer, I, Br ton, V, Dobrev, A, Van Doosselaere, C, Hernandez, V, Herveg, J, Jacq, N, Legré, Y,
Olive, M, Rahmouni, H, Solomonides, T, Stroetmann, K, Stroetmann, V & Wilson, P 2008, The SHARE road
map: Healthgrids for biomedical research and healthcare. in Global Healthgrid: E-Science Meets Biomedical
Informatics - Proceedings of HealthGrid 2008. Studies in Health Technology and Informatics, vol. 138, IOS
Press, pp. 238-278, 6th Annual HealthGrid Conference - Global HealthGrid: E-Science Meets Biomedical
Informatics, HealthGrid 2008, Chicago, IL, United States, 2/06/08.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 25. May. 2021
The SHARE Road Map
1
:




































Centre de recherche informatique et droit, FUNDP, Namur, Belgium 
b
Universidad Politechnica de Valencia, Spain 
c
Centre National de la Recherche Scientifique, Clermont-Ferrand, France 
d
Empirica Gesellschaft für Kommunikations- und Technologieforschung mbH, 
Bonn, Germany 
e
European Health Management Association, Dublin, Ireland (International) 
f
HealthGrid, Clermont-Ferrand, France (International) 
g
University of the West of England, Bristol, UK 
(all affiliations at the time of the commencement of the project) 
Abstract. The HealthGrid White Paper was published at the third annual confer-
ence in Oxford in 2005. Starting from the conclusions of the White Paper, the EU 
funded SHARE project (http://www.eu-share.org) has aimed at identifying the 
most important steps and significant milestones towards wide deployment and 
adoption of healthgrids in Europe. The project has defined a strategy to address the 
issues identified in the action plan for European e-Health (COM(2004).356) and 
has devised a roadmap for the major technological and ethical and legal develop-
ments and social and economic investments needed for successful take up of 
healthgrids in the next 10 years. A “beta” version of the road map underwent full 
review by a panel of 25 prominent European experts at a workshop in December 
2007. The present document is an executive policy summary of the final draft road 
map. It has sought to reconcile likely conflicts between technological develop-
ments and regulatory frameworks by bringing together the project’s technical road 
map and conceptual map of ethical and legal issues and socio-economic prospects. 
A key tool in this process was a collection of case studies of healthgrid applica-
tions.
Keywords. Healthgrid; Biomedical Informatics; Grid Computing – Research 
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Economic Issues (ELSE); Epidemiology; Innovative Medicine; Genomic & Indi-
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Grid technology has been identified as one of the key technologies to enable and sup-
port the ‘European Research Area’. This new paradigm offers rapid computation, large 
scale data storage and flexible collaboration by harnessing together the power of a large 
number of commodity computers or clusters of other basic machines. The grid was 
devised for use in scientific fields, such as particle physics and bioinformatics, in which 
large volumes of data, or very rapid processing, or both, are necessary. The impact of 
this concept is expected to reach far beyond eScience, to eBusiness, eGovernment and 
eHealth. However, a major challenge is to take the technology out of the laboratory to 
the citizen. 
The concept of grids for health was born in Europe in 2002 and has been carried 
forward through the HealthGrid initiative [1]. This European collaboration has edited a 
white paper setting out for senior decision makers the concept, benefits and opportuni-
ties offered by applying newly emerging grid technologies in a number of different 
applications in healthcare [2]. Starting from the conclusions of the White Paper, the EU 
funded SHARE project [3] aimed at identifying the important milestones towards wide 
deployment and adoption of healthgrids in Europe. The project has devised a strategy 
to address the issues identified in the action plan for a European e-Health [4] and has 
devised a roadmap for the major technological developments, legal and ethical barriers, 
and socio-economic investments needed for successful uptake of healthgrids in the next 
ten years. 
The roadmap proposed by the SHARE project expresses certain measurable goals 
and objectives for the HealthGrid community, provides an analysis of the technical 
gaps to be bridged in order to achieve a number of staged technical objectives, explores 
the ethical, legal and socio-economic (ELSE) conditions of such developments, analys-
ing the extent to which technology and its environment will need to be reconciled, and 
articulates a strategy for the concurrent achievement of these goals and objectives sub-
ject to realistic contextual conditions. 
This roadmap has been developed from three major inputs: 
a) an analysis of user requirements in a carefully triangulated set of domains 
through current projects and scripted use-cases; 
b) a technical road map which sets out the key objectives for a viable ‘knowl-
edge healthgrid’ to be achieved in a span of 10-15 years; 
c) a conceptual map of ELSE conditions, constraints and requirements which 
must be addressed before a knowledge healthgrid can be deployed in a real 
healthcare setting. 
The conceptual map of ethical, legal and socio-economic issues considered the 
regulatory challenges that any real healthgrid must meet: 
• Legal challenges concerning rights to privacy and confidentiality, ‘right to 
know’ and duty of care. 
• Ethical challenges concerning primary and secondary use of data whether in-
dividual or aggregated. 
• Legal and ethical challenges concerning provenance and quality of informa-
tion.
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• Legal, ethical and economic challenges to the use of healthcare data in com-
mercial and public research, including questions of ownership of data. 
• Legal and ethical challenges in the communication of genetic information and 
the resultant ‘lateral leakage’ of information. 
• Legal and ethical challenges to the communication of medical data across 
borders. 
• Social and legal challenges concerning the formal professional competencies 
of different healthcare actors. 
• Legal, ethical and socio-economic challenges of ‘exceptional cases’, such as 
assisted reproduction, organ donation and transplantation. 
The proposed road map brings all these concerns together into one strategic plan. 
1.2. What are Healthgrids? 
The White Paper [2] defines the concept of a healthgrid as follows: 
Healthgrids are grid infrastructures comprising applications, services or middleware com-
ponents that deal with the specific problems arising in the processing of biomedical data. 
Resources in healthgrids are databases, computing power, medical expertise and even 
medical devices. 
A healthgrid is an environment in which data of medical interest can be stored and 
made easily available to different actors in the healthcare system, physicians, allied 
professions, healthcare centres, administrators and, of course, patients and citizens in 
general. Such an environment has to offer all appropriate guarantees in terms of data 
protection, respect for ethics and observance of regulations; it has to support the notion 
of ‘duty of care’ and may have to deal with ‘freedom of information’ issues. Working 
across member states, it may have to support negotiation and policy bridging.
Early grid projects, while encompassing potential applications to the life sciences, 
did not address the specificities of an e-infrastructure for health, such as the deploy-
ment of grid nodes in clinical centres and in healthcare administrations, the connection 
of individual physicians to the grid and the strict regulations ruling access to personal 
data. However, a community of researchers did emerge with an awareness of these is-
sues and an interest in tackling them. 
1.3. The HealthGrid Initiative 
Pioneering projects in the application of grid technologies to the health area have re-
cently been completed, and the technology to address high level requirements in a grid 
environment has been under development and making good progress. Because these 
projects had a finite lifetime and the healthgrid vision required a sustained effort over a 
much longer period, and besides because there was an obvious need for these projects 
to cross-fertilise, the ‘HealthGrid initiative’, represented by the HealthGrid association 
(http://www.healthgrid.org), was initiated to bring the necessary long-term continuity. 
Its goal is to encourage and support collaboration between autonomous projects in such 
a way as to ensure that requirements really are met and that the wheel, so to speak, is 
not re-invented repeatedly at the expense of other necessary work. 
The HealthGrid community identified a number of objectives [5]: 
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• Identification of potential business models for medical grid applications. 
• Feedback to the grid development community on the requirements of the pilot 
applications deployed by the European projects. 
• Development of a systematic picture of the broad and specific requirements of 
physicians and other health workers when interacting with grid applications. 
• Dialogue with clinicians and those involved in medical research and grid de-
velopment to determine potential pilots. 
• Interaction with clinicians and researchers to gain feedback from the pilots. 
• Interaction with all relevant parties concerning legal and ethical issues identi-
fied by the pilots. 
• Dissemination to the wider biomedical community on the outcome of the pi-
lots.
• Interaction and exchange of results with similar groups worldwide. 
• The formulation and specification of potential new applications in conjunction 
with the end user communities. 
Apart from research, where the value of grid computing is well established, a 
healthgrid may be deployed to support the full range of healthcare activities, from 
screening through diagnosis, treatment planning to epidemiology and public health. For 
example, anticipating that population trends, air pollution and global warming may lead, 
through extremes of heat, to increased risks for the elderly, we may deploy a monitor-
ing service to track conditions and medical episodes in hot summers. 
The results of several major studies of the interface between bioinformatics and 
medical informatics have been published with a remarkable promise of synergy be-
tween the two disciplines, leading to what had already begun to be referred to as ‘per-
sonalised medicine’ [6–8]. From the point of view of HealthGrid, this made clear the 
need to unify the field and to put its various elements in perspective: how would they – 
improved evidence bases, imaging, genetic information, pharmacology, epidemiol-
ogy – fit together, what was their relative importance in the unfolding programme of 
work? 
Given the source of the concept of grid in the physical sciences, many require-
ments arising out of the biomedical and healthcare fields were not a central concern to 
the grid development community. Indeed, even today, when these requirements have 
been fed through to the middleware services community, they are not always or neces-
sarily a priority for the developers. Thus HealthGrid has been actively involved in the 
definition of requirements relevant to the development and deployment of grids for 
health and was among the first to identify the need for a specialist middleware layer, 
between the generic grid infrastructure and middleware and the biomedical or health 
applications. 
Among data related requirements, the need for suitable access to biological and 
medical image data arose in several early projects, but for the most part these are pre-
sent in other fields of application also. Looking to security requirements, most of these 
are special to the medical field: anonymous or private login to public and private data-
bases; guaranteed privacy, including anonymization, pseudonymization and encryption 
as necessary; legal requirements, especially in relation to data protection, and dynamic 
negotiation of security and trust policies while applications remain live. Most adminis-
trative requirements are common to medicine and eScience, although the flexibility of 
‘virtual grids’, i.e. the ability to define sub-grids with restrictions on data storage and 
data access and also on computing power, is more obviously required in healthcare. 
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Medical applications also require access to small data subsets, like image slices and 
model geometry. At the (batch) job level, medical applications need an understanding 
of job failure and means to retrieve the situation. 
1.4. The SHARE Project: From White Paper to Road Map 
In the White Paper, the HealthGrid community expressed its commitment to engage 
with and support modern trends in medical practice, especially ‘evidence-based medi-
cine’ as an integrative principle, to be applied across the dimensions of individual 
through to public health, diagnosis through treatment to prevention, from molecules 
through cells, tissues and organs to individuals and populations. In order to do this, it 
had to address the question how to collect, organise, and distribute the ‘evidence’; this 
might be ‘gold standard’ evidence, i.e. peer reviewed knowledge from published re-
search, or it might be more tentative, yet to be confirmed knowledge from practice, and, 
in addition, would entail knowledge of the individual patient as a whole person. The 
community also had to address the issues of law, regulation and ethics, and issues 
about crossing legal and cultural boundaries, finding ways to express these in terms 
that translate to technology – security, trust, encryption, pseudonymisation. Then it had 
to consider how the services of the healthgrid middleware would satisfy these require-
ments; and, if it was to succeed in the real world, how to make the business case for 
healthgrid to hard-pressed health services across Europe while they are struggling with 
their own modernisation programmes. 
The vision of health that informs the thinking of the White Paper and the work of 
HealthGrid since its publication has been defined in the ‘Action Plan for a European e-
Health Area’ [4] as follows: 
“… the application of information and communications technologies across the whole 
range of functions that affect the health sector. e-Health tools or ‘solutions’ include prod-
ucts, systems and services that go beyond simply Internet-based applications. They include 
tools for both health authorities and professionals as well as personalised health systems 
for patients and citizens. Examples include health information networks, electronic health 
records, telemedicine services, personal wearable and portable communicable systems, 
health portals, and many other information and communication technology-based tools as-
sisting prevention, diagnosis, treatment, health monitoring, and lifestyle management.” 
In the light of the White Paper and its impact, the EC funded a ‘specific support 
action’ project, SHARE, to explore exactly what it would mean to realise the vision of 
the White Paper, investigate the issues that arise and define a roadmap for research and 
technology which would lead to wide deployment and adoption of healthgrids in the 
next ten years. 
2. The Benefits of Healthgrids 
2.1. For the Healthcare Professional/Biomedical Researcher 
Healthcare systems both in developed and in developing countries face major economic 
and capacity challenges to maintain quality of care in the face of the growing demands 
of ageing populations and the increasingly sophisticated treatments available. Add to 
this the desire to improve access to new care methods, and the challenge of delivering 
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care becomes significant. In an attempt to meet these demands, health systems have 
increasingly looked at deploying information technology to scale resources, to reduce 
queues, to avoid errors and to provide modern treatments into remote communities, for 
example.
From the individualized care point of view, in order for clinicians to make the best 
diagnosis and decide on treatment all the relevant health information of the patient 
needs to be available and transparently accessible to them regardless of the location 
where it is stored. Moreover, computer-aided tools are now essential for interpreting 
patient-specific data in order to determine the most suitable therapy from the diagno-
sis [9]. 
To store and process medical images, genetic information and other patient data, a 
large amount of computing power is needed. Large computing resources are also 
needed for keeping statistics of patient records, for knowledge extraction using data 
mining, and for the simulation of organisms and diseases using complex biomedical 
models. Grid technology has undoubtedly much to offer medical professionals, as illus-
trated by the following examples [11]. 
However, the modernisation process faces significant challenges: 
• Connecting and understanding patient records across organisation structures 
and even national borders. 
• Ensuring that information is secured and those accessing it are authorised and 
authenticated. 
• Discovering trustworthy sources of information for comparison. 
• Handling a huge volume of data, especially that involved in genetic medicine 
for instance. 
• Applying traditional information networks and technology into healthcare. 
The delivery of medical information and certain services through the internet is 
familiar. In healthgrid computing, we seek an extension of the concept to consider how 
to provide large scale services to the user on demand. Some examples will serve to 
illustrate:
i. Consider a radiologist who needs to manipulate an image: we want to provide 
a set of services, some of which may require heavy processing, making them 
available on her desktop ‘transparently’, as if they were programs simply run-
ning on her computer. 
ii. Consider a public health service which monitors certain infectious diseases 
and has to trigger an alert in case of a suspected epidemic. The identification 
of unusual patterns would in many cases be the critical step to halting the 
problem. 
iii. Consider a surgical simulation prior to maxillofacial surgery, to determine 
how the patient’s face may appear after one manoeuvre versus another, the 
presence of sufficient tissue to allow the operation or to demand transplanta-
tion, and even to involve the patient in the decision. 
iv. Consider a ‘neglected disease’ like malaria. Malaria is neglected by the phar-
maceutical industry because there is no prospect of profit in it. Relatively little 
progress has been made towards the eradication of this well understood dis-
ease, notwithstanding substantial investments of public funds in research pro-
jects. In silico lead generation may possibly be coupled with investment in 
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plant by the poorer nations that suffer from it to lead to a locally sustainable 
solution. 
v. Consider the possibility of linking genomic information to imaging in diseases 
like juvenile idiopathic arthritis. The genome will indicate susceptibility long 
before the disease is expressed, but equally, signs picked up from imaging 
may obviate the need for genetic screening, thus avoiding some of the most 
acute problems associated with it. 
vi. Consider more abstractly the nature of evidence-based practice, the volume of 
scientific literature that provides the evidence base and the accumulation of 
evidence from practice that occurs as a matter of routine healthcare. How can 
these be integrated? How can they be used without violating any ethical re-
strictions on use of data, confidentiality, privacy, security? How can they be 
shared without violating any data protection laws? 
However, there are problems even among these optimistic scenarios. Standards 
have not stabilised in the grid world, so data exchanges will present problems straight 
away. Codes and coding languages are also still not universally adopted, while the ap-
plication provider will wish to protect investments in software licence rights. 
2.2. For the Technologist 
The SHARE roadmap for the adoption of healthgrids constitutes a critical analysis of 
the status of grid and other supporting technologies for the advance on the integration 
and processing of large scale eHealth and biomedical data. 
From the technologist’s point of view, this document outlines the deficiencies, 
gaps and promising technological research lines that are necessary for achieving a rea-
sonable degree of maturity in healthgrids. Therefore, it can be seen as a list of opportu-
nities for collaborations, new working lines and technology transfer. 
In this sense, four technological areas are considered: 
• Computing challenges. Issues related to the reliability, quality of service, 
lightweight middleware and compatibility on health networks require specific 
actions which are outlined. 
• Data grid challenges. Issues related to data federation, effective update of da-
tabases, scalability and privacy management are considered and analysed. 
• Collaboration grid challenges. Issues related to workflow definition, threading 
processes, ‘playing’ with data, adjusting images, consulting colleagues, com-
paring and contrasting, have been analysed at greater length in eScience pro-
jects than in healthgrids. 
• Knowledge challenges. The evolution to future knowledge services through 
the semantic integration of services, semantic data analysis and federation are 
medium and long term issues which should be started now through basic re-
search. 
These technological challenges are summarised in several milestones that are de-
scribed in the final section of the roadmap. 
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2.3. Socio-Economic Benefits 
Modern healthcare services are expected to be available around the clock, seven days a 
week, so that systems with pervasive access and near-absolute fault tolerance are indis-
pensable. However, it is difficult for these applications to run non-stop with a high 
quality of service. Grids could help by providing a platform of collaboration, allowing 
the linking centres which co-operate to achieve better continuity and quality of service. 
Medical staff will then be able to share experience, knowledge and ‘second opinion’ 
with other internal and external staff. The distributed architecture of grids with the 
availability of high-bandwidth networks responds well to the requirements of health-
care provision. There are also optimistic stakeholders’ views towards medical research, 
healthcare and computing capabilities combined to better satisfy the patient [10]. 
Healthgrids promise many benefits to mobile patients as well as citizens. It could 
help a travelling individual to receive the right treatment in an emergency situation, 
thanks to the ability of the grid to facilitate communication between the local hospital 
of the patient and the admitting hospital abroad in order to exchange necessary heath 
related information. 
In addition, healthgrids enable the mobility of a patient within EU states and allow 
them to receive medical treatment in a country of their choice. This could help solve 
problems of long waiting lists in states with busy hospitals and lack of medical staff. In 
economic terms, the grid could provide an optimal solution for healthcare. It allows a 
better use of resources and maintenance of tasks, an improved global IT organisation, 
scalable costs, and a large and consolidated IT business within the healthcare organisa-
tion [11]. 
Heath tourism is a growing concept which can enrich the economy of countries 
where modern medical treatments (plastic surgery, dental surgery, reproductive medi-
cine, laser surgery for vision correction, etc.) are evolving and having higher success 
rates than others. This domain can benefit from healthgrid technology as it facilitates 
the exchange of patient heath records and the communication between foreign hospitals 
and heath insurance companies to facilitate the referral and payment process. 
Transferring medical images for the purpose of a second opinion to another hospi-
tal requires high bandwidth connections between hospitals. Healthgrid technology can 
provide automated workflows that could be considered a better alternative to manual 
workflows, such as agreement over the phone and fax transmission of data. These 
manual workflows are still used by clinicians at present, but are labour-intensive and 
can cause errors [10]. 
3. Use Cases, User Requirements and Challenges 
3.1. Grid Paradigms 
Grids are often differentiated into computational, data and collaboration grids. The 
ideal grid, envisaged as a servant of a new paradigm of scientific research called ‘e-
science’, must provide transparent processing power, storage capacity and communica-
tion channels for scientists who may from time to time join the grid, do some work and 
then leave, so that the alliances they form in their scientific endeavours might be de-
scribed as ‘virtual organisations’ or VOs for short. Different sciences have different 
needs, and the grid concept has become differentiated: particle physics generates enor-
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mous amounts of data which must be quickly stored, but not necessarily instantly proc-
essed; on the other hand, data in bioinformatics is not large by comparison – it is, of 
course, in plain terms, large – but requires intensive processing. In extending the appli-
cation of grid computing to e-health, another feature becomes pre-eminently necessary: 
that of collaboration. 
3.2. Computing Grids: An Example from Innovative Medicine 
Drug discovery is the long term, multi-stage and high cost process by which drugs are 
discovered and/or designed. The drug discovery goal is to find new molecules that bind 
with specific macromolecules known to play a key role in a disease process, in a man-
ner that changes their function, either to increase resistance to or to reduce the viru-
lence of some pathogen. Reducing the research time in the discovery stage and having 
enhanced information about substances affecting the selected target (‘leads’) are key 
priorities for pharmaceutical companies worldwide. 
In silico drug discovery, including analysis of the gene expression data, target 
function prediction and target three-dimensional (3D) structure prediction, is one of the 
most promising strategies to speed up the drug discovery process, avoiding time con-
suming and costly in vitro and in vivo tests. In silico drug discovery contributes to in-
creasing biological system knowledge, to managing data in a collaboration space, to 
speeding up analysis and consequently improving the success rate compared with the 
traditional “wet” approach. The efficiency gains of such an integrated knowledge sys-
tem could result in 35% cost savings, or about US$300 million, and 15% time reduc-
tion, or two years of development time per drug. 
In silico drug discovery requires advances in data integration (including data 
format standardisation, dataflow definition in a distributed system, services for data and 
meta-data registration, and development and sharing of ontologies and knowledge rep-
resentations), workflow enactment to ease data management and data mining and to 
assist the scientist and the decision-maker in organising their work in a flexible manner, 
access to computing and data resources (computing 1 million docking probabilities 
or modelling 1000 compounds on one target protein requires a few TFlops for one day), 
and collaboration between public and private partners, involving the concrete shar-
ing of data and knowledge, software and workflow, and infrastructures such as comput-
ing, storage and networks. Security and the effective protection of intellectual property 
and sensitive information are key challenges for pharmaceutical industries, but also for 
academic institutes in most cases. 
3.2.1. Challenges and Requirements 
The European Federation of Pharmaceutical Industries and Associations (EFPIA) iden-
tified pre-competitive barriers to innovation. The objective for the future would be to 
identify as soon as possible in the pre-clinical phase the reasons for lack of efficacy, 
despite promising pre-clinical data, and the potential for adverse drug reactions and 
pre-clinical toxicity. The identified key bottlenecks in the R&D process are: 
• predictive pharmacology at the discovery research stage; 
• predictive toxicology at the preclinical development stage; 
• identification of biomarkers at the translational medicine stage; 
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• patient recruitment and validation of biomarkers at the clinical development 
stage;
• risk assessment with regulatory authorities at the pharmacovigilance stage. 
The knowledge management area is identified as key to leveraging the potential of 
new technologies such as genomics and proteomics and to analyse the huge quantity 
and diversity of information in an integrated way, such as the capture, analysis and 
interpretation of knowledge generated for one potential drug candidate from discovery, 
non-clinical and clinical development all the way to lifecycle management. One of the 
major bottlenecks is the lack of availability of databases across R&D that might facili-
tate data integration. 
3.3. Data Grids: An Example from Epidemiology 
One relevant example of health applications for data grids is epidemiology. The epide-
miology use case is defined as a system able to link the information from distributed 
and heterogeneous databases, identify patients, complete episodes and automatically 
improving quality without interrupting clinical practice. With this data, complex epi-
demiological models are fed and simulated producing aggregated prospective results, in 
a reliable way. This use case is representative of different applications and systems 
including ontological information systems, infectious surveillance networks, pharma-
epidemiology analysis of efficiency and cost, and study of propagation models for dis-
eases.
The main users (from the highest-concept level to lowest) are public health au-
thorities, epidemiologists and pharmaceutical companies. The data is normally owned 
by clinical care (both public and private). In order to achieve this use case the user 
needs to go through different steps including automatic data gathering, data quality 
improvement, processing of the data, and presentation of results. 
3.3.1. Challenges and Requirements 
The main challenges to this use case include the general problem of access to distrib-
uted, critically sensitive and heterogeneous data, resulting in costly computing proc-
esses. Patient-centric analyses normally deal with smaller amounts of data and require a 
pre-existing knowledge of models of healthy and diseased organs or tissues. Popula-
tion-level analyses normally deal with the integration of larger, poorer-quality data. 
Semantics are especially relevant in those approaches. 
The research requirements for the epidemiology use case can be summarised as 
follows: 
• Effective semantic annotation of data. Data is poorly coded and interoperabil-
ity of coding is not trivial. Extracting knowledge from medical data, however, 
is a main objective. 
• Effective integration of distributed and heterogeneous data. Integrating dis-
tributed resources requires exchange protocols, secure mechanisms, patient 
de- and re-identification, and automatic data analysis services. 
• Availability of efficient infrastructures and usage policies. Applications will 
require sufficient resources and a reliable infrastructure to work on under a 
clear Quality of Service (QoS) promise. 
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• Robust security mechanisms insuring that the different components of the in-
frastructure behave in way that conforms to the European norms controlling 
the handling of personal data. 
• User-friendliness of applications and services. The tools should be available 
through protocols and interfaces similar to those used in the users’ normal re-
search. Not only must the applications be as compliant as possible with cur-
rent systems and interfaces, but so must the technologies. 
• Ensuring that the research is done in a secure, ethically and legally compliant 
framework. 
• Reliability, scalability and pervasiveness. All the previous services must be 
robust and should be scalable without reducing performance. 
3.4. Collaboration Grids: AN Example from Virtual Physiological Human (VPH) 
The EuroPhysiome initiative has led to the concept of Virtual Physiological Human 
(VPH), indicating a methodological and technological framework that once established 
will enable the investigation of the human body as a single complex system. VPH will 
provide a framework within which observations made in laboratories, hospitals, and in 
the field all over the world can be collected, catalogued, organised, shared and com-
bined in a variety of ways. It should also allow experts to collaboratively analyse ob-
servations and develop systemic hypotheses that involve the knowledge of multiple 
scientific disciplines, and to interconnect predictive models defined at different scale, 
with different methods, and with different levels of detail, into systemic networks that 
provide concretisation to those verifiable systemic hypotheses. 
3.4.1. Challenges and Requirements 
With respect to grid computing, the following challenges and requirements have been 
identified. 
Knowledge management. The accumulative nature of VPH requires that every-
thing is organised within solid knowledge management models. This should make it 
possible to keep even very large information spaces organised and usable.
Fostering grid adoption. To foster grid adoption in the VPH community, it is 
highly recommended to identify a few VPH CPU intensive applications which could 
benefit immediately from deployment on existing grid infrastructures like EGEE or 
DEISA. The deployment of these applications will allow the identification of missing 
services on the existing infrastructures, and will raise the awareness of grids in the 
VPH community.
Access to resources. Researchers require access to all available resources in a uni-
form way, from those provided by their own department to specialised HPC resources. 
Access to these should be as seamless as possible, with simulations at different scales 
being automatically migrated and appropriate resources being used as required.
User friendly interfaces. Current grid portals require the user to specify parame-
ters such as memory to be allocated at execution time; this would not be appropriate for 
VPH users.
Grid usage models. The nature of VPH simulations means that processing is time 
critical, and current models of HPC use would not be appropriate. Instead, models 
which permit a large number of grid nodes to be used for a relatively short time (‘burst 
mode’) with little or no waiting time should be established. Resource co-reservation 
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will also be required, particularly where multiscale simulations that run over multiple 
sites are concerned.
Shared storage for large data/model repositories. The imaging datasets con-
cerned can be several hundred megabytes in size, but after pre-processing to generate a 
predictive model, the modelling and simulation data can be as much as a hundred giga-
bytes in size. With potentially thousands of these, there is a clear need for multi-
terabyte storage facilities, connected to distributed HPC resources via high speed net-
works. These must incorporate the required security and confidentiality measures.
Methods to solve multiple predicted models, in a coupled way. As the coupling 
of predictive models at different scales is central to VPH’s description of human physi-
ology, coupled methods to solve multiple models will be required. This is considerably 
complicated by the fact that the models concerned may be very different both in con-
ceptual nature and mathematical nature. Even relatively simple VPH problems can be 
considerably complicated by variations between individual subjects and treatment pro-
cedures.
Direct prediction from medical images. Methods for transforming a medical im-
aging dataset into a subject specific predictive model that do not require the costly pre-
processing phase are being developed, such as the Boltzmann Lattice in haemodynam-
ics and voxel meshes for hard tissue simulations. However, these are enormously com-
putationally intensive, requiring fifty or more teraflops of computational power to solve 
in less than a day. 
3.5. Knowledge Grids: AN Example from General Healthcare 
For any given domain, a distinction is often drawn between declarative knowledge 
(‘know what’) and procedural or operational knowledge (‘know how’). In the domain 
of healthcare, both kinds occur. What is often referred to as ‘the scientific basis’ of 
medicine, that which must furnish the evidence in so-called ‘evidence-based practice’, 
is present in research publications to which different standards of credibility are at-
tached. For example, research results based on a randomized, double-blind, controlled 
clinical trial are held to be the gold standard, provided they were also submitted to ade-
quate peer review. Evidence based on one physician’s own practice, although not neg-
ligible, would be considerably less reliable. On the other hand, ‘best ways’ of treating 
patients – in a particular context – are often described in integrated care pathways 
(ICPs). It is not unreasonable to claim that declarative knowledge in medicine tends to 
be disseminated through peer-reviewed publication and operational knowledge through 
such things as guidelines and care pathways. In a healthgrid environment, these are 
brought together for the better treatment of patients and at the same time to improve 
research; indeed, the interplay between healthcare and research, e.g. through appropri-
ately controlled ‘secondary use’, would be an important element in a full healthgrid 
environment. 
Chronic obstructive pulmonary disease (COPD) refers to an airway obstruction 
caused by chronic inflammation. It is usually progressive, not fully reversible, and of-
ten occurs as a result of smoking but other factors such as air pollution can also con-
tribute to the development of COPD. In the UK almost 900,000 people have been diag-
nosed with the disease, and the true number of people suffering from the condition is 
estimated to be around 1.5 million. 
According to NHS guidance, the management of the disease should be tailored to 
the individual, with adjustments being made based on responses to treatment. The 
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guidance includes a large number of drugs, including some off-label drugs such as Be-
clometasone, Fluticasone and Budesonide. 
In the UK, the National Institute for Health and Clinical Excellence (NICE) has is-
sued national guidelines for the treatment of the disease, but these are frequently modi-
fied to account for local variations and priorities. As a result, the procedure for assess-
ing and treating the disease will vary even within a single country, let alone between 
countries. The evidence on which this guidance is based comes from a variety of 
sources, such as national studies by NICE and systematic reviews with an international 
scope. 
Two main concerns exist for general healthcare; supporting the travelling patient, 
such as migrating elderly populations, and enabling decision support systems that can 
account for local variations in best practice and clinical evidence. 
3.5.1. Challenges and Requirements 
Evidence from national studies, such as the aforementioned NICE study, may not be 
available to a doctor from a different locale. In order to continue treating the patient 
concerned, the doctor (or decision support system) must be aware of the evidence and 
guideline/pathway that informed the plan of care for that patient, and any deviations 
from that plan that have occurred to date. This may not a trivial matter of simply retain-
ing a link to the relevant material, as there may be language barriers, and local reasons 
why the guidance followed in one country would not be appropriate in another. 
The guidance also mentions drugs that are not certified for the treatment of COPD 
(off-label) despite this evidence coming from high quality systematic reviews. Differ-
ent drugs will be certified for the treatment of the condition in different countries, com-
plicating the process of following a single guideline or pathway regardless of travel. In 
fact, the patient concerned may be travelling for the express purpose of receiving dif-
ferent or less costly treatment in another country. 
Prior history of exacerbations and smoking are essential for properly treating the 
disease, and therefore the doctor concerned must be able to access, comprehend and 
update the patient’s record. This requires standardisation of electronic health records 
(EHRs) and electronic integrated care pathways (eICPs). When it comes to decision 
support, a standard interface format, such as the proposed HL7 vMR [15], will also be 
a necessity. 
4. Technical, Ethical, Legal and Socio-Economic Issues 
4.1. Technical Issues 
4.1.1. Standardisation Issues 
Standards are absolutely necessary for the deployment of services which integrate data 
in bioinformatics and medical informatics, but are also vital for data coming from dif-
ferent medical disciplines and even data coming from different countries in Europe. 
These standards are needed for building data models, producing ontologies and for the 
development of knowledge management services. The adoption of standards for the 
exchange of biological and medical information is still limited to a few specific fields. 
Moreover, they need to be compatible with grid standards so as to allow their imple-
mentation on healthgrids. 
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4.1.2. Communication Issues 
Lack of information about grids and grid technologies is frequently identified as one of 
the key reasons why there has been very little interest in them from the field of medical 
research. It is essential that all relevant actors to be kept well informed by the Health-
Grid community of the potential benefits of the technology to them. Success stories 
demonstrating the impact of grids for medical research will be vital for convincing 
medical researchers of these benefits. As a result, there is a need for a suitable demon-
stration environment, offering very easy access to the grid for non experts and provid-
ing services that will help convince the medical research community. On this dissemi-
nation environment, dedicated efforts to promote the technology can then be developed. 
4.1.3. Security Issues 
Deployment of a data grid for medical research will only be possible when the middle-
ware can provide all the necessary guarantees in terms of management of personal data. 
We perceive the specific technical requirements related to the handling of medical data 
on the grid to be as follows. 
• Manipulation of personal data on the grid must obey strict regulations. These 
regulations vary between European member states. 
• Services for the anonymization and pseudonymization of medical data must be 
provided. 
• Medical data is the property of the patient. A mechanism must be set up to al-
low individuals to access their data on the grid. 
• For healthcare purposes, the authentication of healthcare professionals on the 
grid cannot be handled by requesting all of them to get a grid certificate. A 
mechanism must be set up so that professional cards can be used to provide 
authentication on the grid. 
4.2. Legal Issues 
4.2.1. Data Protection 
The ethical principle of autonomy is legally underpinned by the duty of data protection. 
This is taken very seriously at EU level; as well as the inclusion of privacy protection 
in the European charter of fundamental rights, the EU has developed the robust direc-
tive on data protection to promote privacy. 
However, the current legislation is not adequate to support most of the longer run-
ning research initiatives around which healthgrids are based [12]. As the current EU 
level legislation stands, member states can enact specific legislation covering specific 
tools such as healthgrids in order to exempt scientists and medical practitioners using 
healthgrids from some of the more onerous duties of the directive. 
No member state has addressed legislation to this particular issue and so health-
grids are burdened with onerous data protection requirements which could deter scien-
tists from adopting healthgrid technology and using its enhanced computational and 
data acquisition power. 
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EU level legislation on liability for goods and services is reasonably well developed, 
but does not in its present form lend itself well to the healthgrid domain. One of the 
reasons for this is, of course, that health services are organised at national or regional 
level and that the European Union has no legal competence to draw up legislation 
which states specifically how a health service should be organised. However, the EU 
does have a range of legislation designed to protect citizens from harm resulting from 
goods offered on the market [13]. Steps could be taken using guidelines, or even spe-
cific legislation, to address distributed computing services such as healthgrids that 
would seem at present to be only marginally covered by the existing rules. Accordingly, 
it is important that the existing European framework of general product safety be re-
examined to consider its applicability to distributed networks such as healthgrids. 
4.2.3. Intellectual Property 
In the EU, legislation dictates that the owner of copyrighted software running a health-
grid has exclusive rights to reproduce his work, produce derivative works, distribute 
copies to the public, and perform and/or display the work publicly. Under these cir-
cumstances any natural or legal person would have to pay to use the computer pro-
grams that constitute one of the most important components of healthgrids.
An open standards approach to software co-development could help in the devel-
opment and implementation of healthgrids. The open source licensing model actually 
uses copyright and contract principles to retain control of the work while enabling its 
use effectively for free, and could thus encourage use and development. 
4.3. Organisational, Social and Cultural Issues in the Use of Healthgrids 
Both at the individual and the societal level, issues like universality of availability of 
full healthcare services to all citizens, equal access to healthcare, and equally high qual-
ity of services rendered are key issues [14]. Geographical factors relate mainly to equal 
access to quality care independent of location. ICT-based systems pose new problems 
like access to EHRs by insurance companies or employers, and even police and prose-
cutors. The opinions and attitudes of patient and citizen associations and lobbying 
groups, often magnified by the media, could have a strong impact through public (pol-
icy) discussions of these topics on the implementation and diffusion of healthgrids. 
The organisational level is always complex. Perspectives, confirmed by two recent 
research studies, include: 
• Changing care pathways that need new information, skills, knowledge and 
processes for healthcare providers. 
• Changing roles of healthcare professionals, teams and healthcare organisa-
tions.
• The transfer of roles between healthcare professionals, teams and healthcare 
organizations. 
• Increased collaborative working and exchange of information between pro-
viders. 
• New relationships between citizens and healthcare professionals and organisa-
tions.
• New strategic partnerships for third party financers and healthcare providers. 
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Cultural issues are a key factor in health services, including the great diversity of 
attitudes, behaviour and knowledge exchange among professional and non-professional 
staff involved in healthcare, and the impact this has on the quality, efficiency and or-
ganisation of services. Education and training, professional standards and bodies, rules 
and regulations, attitudes and behaviour all have an influence here.
5. Recommendations and Roadmaps 
Objectives have been formulated in terms of milestones according to a number of key 
criteria:
• Is the proposed healthgrid essentially a computational grid, a data grid or a 
collaboration grid? Could it potentially develop into a knowledge grid? 
• Is the necessary development to achieve any given stage likely to be delivered 
by generic grid research or is it particular to healthgrids? 
• Is some prerequisite standard or other agreed framework necessary for the 
achievement of any particular milestone? 
5.1. Health Research Challenges from User CommunitIES’ Requirements 
The analysis of the user community requirements documented in the previous section 
show very clear patterns: 
• Knowledge management is what researchers need. Computing and data stor-
age resources are not sufficient although it is expected they can be accessed in 
a transparent and ubiquitous way; 
• Although the existing grid infrastructures do not provide all the services 
needed by the user communities, they already permit a number of tasks of sci-
entific relevance. As a consequence, deployment of scientific applications 
should be started as soon as possible in order to foster grid adoption and to 
clearly identify the existing gaps; 
• The technological complexity must be hidden from users. Grids are perceived 
as potential infrastructures in so much as their use does not require adaptation 
or acquisition of skills; 
• The communities examined expressed the need for developing the technology 
for distributed data management, and while the usage of grids for distributed 
computing is perceived as available it is still very complex. 
In the rest of this section, we have attempted to translate the requirements of three 
communities (epidemiology, innovative medicine and VPH) into a number of health 
research challenges and deployment milestones. 
• The health research challenges are technical issues which need to be ad-
dressed in order for grids to offer services needed by the health communities. 
• The health deployment milestones are health applications that should be de-
ployed on grids in order to demonstrate their relevance, to identify existing 
limitations and to quantify the progresses made. 
The research challenges have been classified according to their relevance to com-
puting, data, collaboration and knowledge grids. We have also identified several that 
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are not specific to grids but which are needed for the deployment of knowledge grids, 
such as the definition of agreed standards and ontologies within research communities. 
5.1.1. Health Research Challenges for Computing Grids 
Table 1 lists the research challenges identified from the requirements expressed by the 
research communities for computing grids (RCCG). They focus mainly on user friend-
liness, interoperability, quality of service and on demand access: 
• User friendliness (RCCG5) is needed in order for the communities to use the 
grids without having to learn complex procedures. To make the grid user 
friendly, its operating system must be fault tolerant (RCCG6). The complexity 
should be hidden to the point the use of grids become transparent (RCCG4, 
RCCG3). 
• The need to access resources on clusters and supercomputers raises the need 
for interoperability between grid infrastructures (RCCG3). The transfer of 
jobs between infrastructures should also be made transparent to the user to 
ease his work (RCCG1). 
• The quality of service is particularly critical for biomedical applications in re-
lation to healthcare (RCCG8). This includes the need for a scalable job sched-
uling system (RCCG9), the availability of a robust middleware easy to install 
in health environments (RCCG7) as well as resources with low latencies and 
high performance (RCCG10). 
• On demand access to the resources (RCCG2) raises technical and political as 
well as financial issues as to who pays for operating the infrastructures. 
The four key words we will keep to characterise the research challenges for com-
puting grids are user friendliness, interoperability of infrastructures, quality of service 
and on demand access. 
Dependencies for these challenges, grouped by key words, can be seen in Fig. 1. 
Table 1. Health Research challenges for a computing grid 
Research
challenge name 
Description of the health research challenges 
RCCG1 Automatic migration of simulations between different scales and platforms 
RCCG2 Capacity to access grid resources on demand, without previous agreement or 
request. European grid infrastructures should be freely accessible to European 
projects
RCCG3 Capacity to submit jobs to cluster and supercomputer grids in a transparent way. 
Easy transfer of tasks between grid infrastructures 
RCCG4 Transparent access. The users should ignore they are using one grid or the other 
RCCG5 User friendly access. Lower barrier to adoption. 
RCCG6 Real fault-tolerant scheduling systems 
RCCG7 Grid middleware that can be installed in health environments seamlessly and 
without requiring exhaustive maintenance and administration. 
RCCG8 Services in the infrastructures to define exploitation models and guarantee a Quality 
of Service. Need to consolidate the booking of resources in advance and to 
guarantee a pre-negotiated Quality of Service. 
RCCG9 Scalable job scheduling system 
RCCG10 Integration of resources with low latencies and high performance. 
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Although largely arranged by level of complexity, certain milestones are prerequi-
sites for others. For example, for true transparent access to multiple grids and infra-
structures (RCCG4) and similarly the transfer of tasks between infrastructures 
(RCCG3), it will first be necessary to enable on demand access to grid infrastructures 
without prior agreement (RCCG3). 
It should be noted that work towards achieving these milestones is expected to be 
done in parallel. Although this ideal timeline reflects dependencies (to some extent), it 
is also the case that the demand for various developments arises from different quarters 
with plans and development programmes working towards their achievement at differ-
ent stages of progress. In any case, we observe that computing grids are at a more ad-
vanced stage in their development in general, so that work in progress here may fairly 
be expected to support and facilitate progress in data grids and, as they emerge, knowl-
edge grids. 
5.1.2. Health Research Challenges for Data Grids 
Table 2 presents the research challenges for a data grid (RCDG). Some of these chal-
lenges seem to be common to computing grids like the need for quality of service 
(RCDG5), including the availability of a robust middleware easy to install in health 
environments (RCDG4). But these challenges require different skills and content. 
On demand access 
Quality of service 














Figure 1. Dependencies for computing grid research challenges. 
Table 2. Health Research challenges for a data grid 
Research
challenge name 
Description of the health research challenges 
RCDG1 Scalable data cataloguing and data transfer. 
RCDG2 Storage services designed to ease the upload and download of large binary objects 
RCDG3 Develop enhanced standards for data protection in a web services environment  
RCDG4 Grid middleware that can be installed in health environments seamlessly and 
without requiring exhaustive maintenance and administration. 
RCDG5 Services in the infrastructures to define exploitation models and guarantee a 
Quality of Service. Need to consolidate the booking of resources in advance and to 
guarantee a pre-negotiated Quality of Service. 
RCDG6 Data architectures and tools that implement private data dissociation, 
pseudo-anonymisation and encryption, and that are able to fulfil the legal 
requirements in the matter of data management. 
RCDG7 Distributed data models and repositories adapted to the multiscale nature of the 
data needed and generated by the health community  
I. Andoulsi et al. / The SHARE Road Map: Healthgrids for Biomedical Research and Healthcare 257
Global Healthgrid : e-Science Meets Biomedical Informatics, edited by T. Solomonides, et al., IOS Press, 2008. ProQuest Ebook
         Central, http://ebookcentral.proquest.com/lib/antwerpen/detail.action?docID=363216.

























Some challenges are related to basic data management services which are still to 
be developed such as scalable data cataloguing and data transfer (RCDG1) as well as 
upload and download of large binary objects (RCDG2). Further developments include 
services to provide security in the management of the medical data (RCDG6) related to 
the adoption of standards (RCDG3). 
The need for distributed data models (RCDG6, RCDG7) is also expressed. 
The key words we will keep to characterise the research challenges for data grids 
are improved distributed data management, quality of service and distributed data 
models.
The dependency diagram for these milestones, grouped by key words, can be seen 
in Fig. 2. 
It should be noted that quality of service (QoS), a key word for computing grids, is 
also an important area for data grids. The milestones RCCG7/RCDG4 and RCCG8/ 
RCDG5 respectively are similar, although there will be differences in the specific re-
quirements for QoS between computing and data grids. 
Naturally, there is a significant emphasis on the handling of data. Most questions 
will have already occurred in some guise or other in the field of distributed databases, 
but they reappear here with force in view of the autonomy of nodes within virtual or-
ganisations and especially the critical control that (non-virtual) organisations in the 
healthcare and biomedical domains must exercise over their data. 
Developments in computing grids are anticipated to support the evolution of data 
grids, although there is no simple correspondence between the different concerns and 
drivers in the two paradigms. Indeed, it is important to observe that the principal con-
cern of data grids, the management of its transparently distributed data, may be ad-
dressed in parallel with the majority of issues in computing grids. This is happening in 
several quarters in some cases independently of computing grid research and elsewhere 
in relation to it. Health-related projects dealing with imaging in particular, such as the 
EPSRC-funded Integrative Biology project [14] and the EC-funded Health-e-Child 
project [15], have features common to both computing and data grids. These require 
significant data management facilities for distributed, possibly heterogeneous image 
data, associated annotations and metadata, but also require computational resources for 
biomedical modelling and simulations. 
Distributed data models 
Quality of service 









Figure 2. Dependencies for data grid research challenges. 
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As noted previously, developments in computing grids will support some of the 
work still necessary in the domain of data grids. Fig. 3 illustrates the overlap between 
them.
5.1.3. Health Research Challenges for Collaboration Grids 
Table 3 below catalogues the principal research challenges for collaboration grids, i.e. 
for grid services to support collaboration (RCLG). Biomedical research and healthcare 
are often highly cooperative, multidisciplinary activities, underpinned by informal as 
well as formal networks. While in some healthgrid projects collaboration has been built 
into the design from their very conception, in other cases the need for collaboration will 
arise in the same informal fashion as has arisen in the past. At the same time, many 
modern influences in medicine (e.g. evidence-based practice) have led to the definition 
of ‘protocols’ and ‘care pathways’ which may readily be recognised as workflows, thus 
providing a context for some collaborations. None the less, there is a good deal of 
scope for knowledge and technology transfer from heavily data-driven branches of e-
science, where collaborative workflow engines have begun to be established. 































Figure 3. Combined dependency diagram for computing and data grid research challenges. 
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Table 3. Health Research challenges for a collaboration grid 
Research
challenge name 
Description of the health research challenges 
RCLG1 Migration of e-science workflow engines to biomedical research to encompass 
end-to-end processes, e.g. stages on the road from drug discovery to clinical trial. 
RCLG2 Natural mapping of healthcare/medical protocols to workflows for remote 
collaboration, education or quality control. 
RCLG3 Certification of medical workflows, complying with relevant legal and ethical 
obligations, to ensure they are reliable, validated and updated when required. 
RCLG4 Natural mapping of public health distributed decision support to facilitate 
coordinated action. 
RCLG5 Natural mapping of guidelines, protocols and integrated care pathways to validate 
practice against constantly updated evidence base. 
RCLG6 Ad hoc integration of heterogeneous sources of information where no prior 
coordination has been provided. Integration of different levels or modalities of 
medical data towards multidisciplinary diagnosis and treatment planning. 
RCLG7 Workflow repositories to retain and maintain defined workflows and to enhance 
reuse, repurposing and recycling. Retain workflow histories and outcomes. 
RCLG8 Support for persistent collaborations, esp. in relation to rights management and 
participant privileges. 
RCLG9 Integration and management of workflows with implications in different domains, 
e.g. conflict between medical and ethical calls.  
RCLG10 A forum for the discussion of health/medical workflows, including provenance 
data, and a broader means of discussion and communication between 
collaborators.
Issues of collaboration arise in the context of diagnosis by different specialists, 
second opinion, treatment and surgery planning. Examples would include pipelining 
second reading or second opinion in breast screening; bringing in additional expertise if 
appropriate – e.g. staging a cancer; or quality control of the consistency of histopathol-
ogy findings, by analysis of reports and checking them against guidelines. Monitoring 
in the public health domain may be concerned with MRSA-type epidemics or with 
avian flu or heat wave emergencies. All these call for a different kind of joint action, 
but all may benefit from decision support. More sophisticated epidemiology may be 
possible through analysis of associated data, as in the suggestion that avian flu passes 
more readily among genetically related individuals than among others despite close 
contact [51]. These suggested requirements would be satisfied through a combination 
of knowledge management and workflow management tools, linking the two where 
necessary. 
In another dimension of collaboration, the promise of modern biomedicine to re-
late genomic data to disease phenotypes, is being explored in such projects as Health-e-
Child (HeC) and ACGT [52]. In HeC, there is a need to bring together information not 
only from different levels but also from different modalities, such as genome and imag-
ing data. Thus collaboration here will also mean ability to coordinate different tools 
and modalities as well as integration of knowledge and data. 
Finally, a further development is possible in the context of this discussion, to coor-
dinate ‘publication’ of services and certification/licence issues. 
5.1.4. Health Research Challenges for Knowledge Grids 
Table 4 provides a list of research challenges for knowledge grids (RCKG). These chal-
lenges refer repeatedly to data integration and knowledge management. 
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Figure 4. Dependencies for collaboration grid research challenges. 
Table 4. Research challenges for a knowledge grid 
Research
challenge name 
Description of the health research challenges 
RCKG1 Knowledge-driven grid catalogues and integration based on the metadata.  
RCKG2 Develop standards and models for exposing web services (semantics), scientific 
services, and the properties of data sources, data sets, scientific objects, and data 
elements 
RCKG3 Design standards for and build an expert tool (ontology/schema/rules negotiator) 
for exposing the properties of local sources in a federated environment 
RCKG4 Develop enhanced knowledge representation models and data exchange standards 
for complex systems, presently largely inconsistent or incomplete, looking for 
synergies with other initiatives 
RCKG5 Develop new, domain-specific ontologies, built on established theoretical 
foundations and taking into account current initiatives, existing standard data 
representation models, and reference ontologies 
RCKG6 Design standards for and build an expert tool (services/data negotiator) to guide 
users through the complexities of the data, data models, simulation and modelling 
tools, etc. 
RCKG7 Develop advanced text mining tools for capturing implicit information about 
complex objects, relationships and processes, as described in patents and 
literature, beyond and above simple pair-wise relationships between entities 
Many of these challenges include the definition of standards and ontologies 
(RCKG2, RCKG3, RCKG4, RCKG5, RCKG6). Some challenges are directly related to 
the grid technology itself (RCKG1, RCKG2, RCKG3) while others are more relevant 
to the research area (RCKG4, RCKG5, RCKG6, RCKG7) and therefore not specific to 
the grid technology. In that case, it seems the healthgrid should benefit from the 
knowledge management services once they have been developed by the research com-
munity.
The key words we will keep to characterise the research challenges for a knowl-
edge grid are data integration tools and standards as well as knowledge management 
tools and standards. In addition, we will use the concept of domain specific knowledge 
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management tools and ontologies to characterise the developments which are not spe-
cific to grids but are needed to enable a knowledge grid. 
The dependency diagram for these milestones, grouped by areas, can be seen in 
Fig. 5. 
While work has been done towards many of these milestones, they remain signifi-
cant challenges due to incomplete implementations and immature standards. Many of 
these challenges are as much in the Artificial Intelligence domain as in grid computing, 
with issues ranging from ‘knowledge-driven’ resource and service management to on-
tologies and meta-ontologies for medical knowledge. 
5.1.5. Deployment Milestones 
Table 5 provides a list of deployment actions which were recommended by the research 
communities. These actions are perceived as milestones on the road to healthgrid adop-
tion as their success will pave the way to the adoption of the technology. 
Some actions are more geared towards computing grids (MD3) some are related to 
data grids (MD1, MD4) while others require from the beginning knowledge manage-
ment (MD2, MD5). 
These actions could be started on the existing grid infrastructures in view of the 
present state of the art of the grid technology. However, the quality of the services as 














Figure 5. Dependencies for knowledge grid research challenges. 
Table 5. Deployment milestones 
Deployment 
Milestone name 
Description of the milestone 
MD1 Need for successful pilot applications on epidemiology and VPH that will 
demonstrate the benefits of the technology to foster adoption of grids in the 
community and to identify limitations of existing infrastructures. 
MD2 Need for epidemiology data sources adapted to grid models.and grid-enabled 
gateways to epidemiological data using medical informatics-related connectors, 
such as HL7, DICOM, ENV13606, etc. 
MD3 Build a core reference database of validated experimental and clinical research 
data extracted from the literature 
MD4 Creation of disease-specific European Imaging Networks for establishment of 
standards, validation of imaging biomarkers and development of regional 
centres of excellence. 
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5.2. Proposed Roadmaps 
In this section, we are going to present a technical roadmap for the adoption of the grid 
technology for healthcare. In the previous section, for three families of grids, comput-
ing, data and knowledge grids, we have identified a number of research challenges 
which have been characterised by a few key words. 
Computing grids: 
• user friendliness 
• interoperability of infrastructures 
• quality of service 
• on demand access. 
Data grids: 
• improved distributed data management 
• quality of service 
• distributed data models. 
Knowledge grids: 
• data integration tools and standards 
• knowledge management tools and standards 
• domain specific knowledge management tools and ontologies. 
Extending the model of Fig. 1, Fig. 6 represents how research challenges address 
different layers of services from core infrastructure to applications. The following 
comments can me made from the picture: 
• Interoperability as well as improved distributed data management must be 
core functionalities of the infrastructure. 
• Quality of service is required from both core and healthgrid services for suc-
cessful healthcare / biomedical applications. 
• Healthgrid services should be accessible on demand, in a user friendly way. 
Distributed data models need to be provided as well. 
• Data Integration Tools and Standards are healthgrid services which stand at 
the interface between data and knowledge grids. 
• Knowledge Management Tools and Standards require the availability of 
proper job and data management tools. They stand at the interface between 
generic healthgrid services and the application specific developments. 
• Domain Specific Knowledge Management and Ontologies are under the re-
sponsibility of the research communities. Their interface to the knowledge 
grid is achieved using the Knowledge Management Tools and Standards. 
On the basis of this analysis, we have represented in Fig. 7 the research challenges 
according to their complexity and an estimated time when they should be overcome. 
The figure inspired from The Innovative Medicine Case Study,
2
 also indicates the level 
of adoption by the research communities. As can be seen clearly from the picture, we 
identify several distinct roadmaps: 
2
 SHARE deliverable D5.2a. 
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• research and development for computing grids should allow offering the qual-
ity of services needed for biomedical research and healthcare at a 5-year hori-
zon. 
• data grids are expected to reach maturity at a 10-year horizon as the core tech-
nology is not yet mature. 
• collaboration grids are achievable with different levels of sophistication at dif-
ferent stages. 
• knowledge grids depend on the quality of services for distributed data integra-
tion and the capacity of the research communities to agree on standards and 
ontologies. As a consequence, their maturity is not expected before 15 years. 
This model arises in the field of innovation studies, and distinguishes between: vi-
sionaries, pioneers both in research and applications; early adopters, who recognise the 
potential for rapid benefits and take up the technology quickly, often introducing fur-
ther innovation; early majority who incur relatively little risk in adopting the technol-
ogy; and late majority, those who take virtually no risk and finally adopt a technology 
because there is no other option. 
The diagram depicts priorities: even for early adopters, infrastructure interoperabil-
ity and distributed data management are already necessary; on demand access, usability 
and quality of service are at the first point of inflection, before rapid expansion, while 
with sophisticated AI tools in the later stages, a second inflection occurs and the tech-
nologies become routinely accepted. 
Figure 6. Representation of research challenges and healthgrid layers of services. 
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Figure 7. Research challenges as a function of time and complexity. 
5.3. Mapping ELSE Requirements 
5.3.1. Computing Grids Phase 
Liability
(Products &Services)
Trust and Acceptance 
Assurance
















Research challenges for Computing grids
Legal/Ethical Issues
Socio-Economic Issues
5.3.1.1. Liability Issues 
The current state of EU legislation does not cover liability issues that are specific to 
healthgrids. The following tasks could help minimise liability concerns for healthgrid 
usage. 
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• Analysis and prediction of risks and possible damage to patient health and 
privacy should begin from the outset. 
• Outlining examples of liability concerns specific to the use of healthgrids in 
order to encourage the introduction of new legislation and policies. 
• Good testing strategies for services and products, including testing for product 
safety.
• Good quality assurance for services and products. 
• The use of standard techniques for detecting bugs and faults while dealing 
with infrastructure interoperability. 
5.3.1.2. Trust and Acceptance 
• Pilot projects and prototype applications to demonstrate the use of grid ser-
vices in clinical and research workflows 
• The use of trust based technologies to increase the trustworthiness of grid in-
frastructures 
• Providing feedback and documentation to provide users with clear answers to 
any security concerns. 
5.3.1.3. Cost and Benefits Estimation 
• Ex-ante analyses over time, based on initial pilot experiences. These have to 
focus on ensuring acceptance, technical and regulatory certainty, and suffi-
cient private incentives in the steps to follow 
• Analysis to estimate potential net benefits (i.e. expected benefits less expected 
costs over time), accounting for different risks and for optimism bias in esti-
mations. Such studies will facilitate access to initial funding, but can also be 
beneficial in the necessary dissemination work with the health sector. 



















Research challenges for Data grids
Legal/Ethical Issues
Socio-Economic Issues
5.3.2.1. Data Protection 
• Ensuring the use of standard means of data security within the different data 
management systems of participating infrastructures (encryption, anonymisa-
tion, pseudonymisation, access control, etc.). 
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• Use of data quality assurance mechanisms. 
• Adopting formal ways to audit the regulatory compliance of operational level 
controls. 
• Automation of the collection of patient consent, and ways to allow patients to 
opt in, opt out and withdraw consent. 
• The use of evolving privacy enhancing technologies. 
5.3.2.2. Sustainability Guarantees 
• The development and deployment of data grids will benefit from more fo-
cused prospective assessments of the socio-economic impact in order to iden-
tify existing and potential barriers. 
• Convincing business cases ensuring sustainability. 
• An organisational milestone can be defined here in the move from technol-
ogy/science towards service provision. By that stage, a notable amount of le-
gal and regulatory certainty has to be achieved, so that private incentives can 
be assessed and adjusted (including via government intervention) if necessary. 
5.3.2.3. Education and New Skills Requirements 
• Training and educational programs to increase users’ confidence in the use of 
healthgrid products and services. 
• Adequate documentation and guidance must be available, and where grid in-
frastructures are distributed amongst geographically remote sites there must 
be sufficient communications methods such as video conferencing to ensure 
problems and concerns raised during deployment are dealt with quickly and 
efficiently.
• Investing in technical staff within hospital and research centres to provide 
help with technical problems. 
5.3.3. Knowledge Grids Phase 
Intellectual Properties


















5.3.3.1. Intellectual Property 
• There is a contradiction between intellectual property rights and the needs of 
grid technology, which will require that access to databases, knowledge and 
software is free of rights. Contract law and agreements could be an option to 
regulate the IP issues related to knowledge integration, ontologies and soft-
ware reuse. 
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5.3.3.2. Governance and Delegation 
• The working document on the processing of personal data relating to health in 
electronic health records (EHR) recommends that in the case of health care 
systems that adopt a decentralised data storage model, it could be necessary to 
appoint one central body to be responsible for steering and monitoring the 
whole system and also for ensuring the operation of the system is compatible 
with data protection. It would also be useful if data subjects could address 
their data protection queries to a central body instead of having to search and 
identify the relevant controller among many. The architecture of a healthgrid 
system is similar but even more complex than a distributed system. The idea 
of one data controller might be preferable but more challenging. A discussion 
and analysis highlighting the main issues and benefits surrounding the idea of 
a unique data controller for data stored within a healthgrid domain needs to be 
produced. Linking this to the technological component of the roadmap, this 
could impact on the process of granting permission to access the data. 
5.3.3.3. Policies and Codes of Conduct 
• Discussions should take place between different healthgrid stakeholders to de-
cide on the importance and benefit of applying for new legislation to address 
healthgrid related legal and ethical issues. 
• Once a decision is reached, a framework will need to be distributed to legal 
bodies showing why healthgrid services and products should be considered 
different from other marketed products. It could also present scenarios show-
ing that the current legislation does not ideally cover these issues. 
• Evolving technologies for the automation and enforcement of policies at dif-
ferent infrastructure layers should be explored. 
5.3.3.4. Dissemination and Publicity 
• Dissemination and publicity programmes need to precede the deployment of 
knowledge grids. This includes workshops, conferences, and magazines to at-
tract the user community and build awareness of healthgrid facilities 
• Demonstrate the effectiveness of grid applications in providing healthcare and 
research services while preserving the users’ autonomy. 
5.3.3.5. Ethical Control and Auditing 
• In the UK, every health organisation is now required to have a privacy and 
data protection officer, the so-called “Caldicott guardian”. The establishment 
of similar roles throughout Europe would be a major step towards harmonisa-
tion of ethical practice and compliance in the member states. This may be 
supplemented by the creation of a Europe-wide ethical body composed of 
these European Caldicott guardians, although there is a question about how 
this would relate to the article 29 working party. Operating at a healthgrid 
level, they would be able to judge matters in a European context. This would 
in a sense provide a useful bottom-up approach to confidentiality and privacy 
protection across healthgrids, as opposed to top-down European directives 
• Before the deployment of Data grids should start, the requirements for ethical 
oversight and monitoring should be determined, and the automation of over-
sight facilities should be explored. 
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5.3.4. Benefiting from the Technology 
Despite the best efforts of policy makers to structure and control the use of personal 
data (in this case patient data), incidents of identity theft, identity base fraud, and the 
sale and misuse of data are still occurring, as highlighted by recent stories in the media. 
This may in part be due to a lack of enforcement of high-level legal obligations con-
cerning personal data, and also as a result of the variability of privacy laws due to cul-
tural and national considerations. 
The recent push to enforce legal rules within enterprise infrastructures and busi-
ness processes has initiated several EU and international projects, each aiming to help 
enterprises, organisations and governments to benefit from the use and exchange of 
personal data without compromising individual privacy. As a result, many privacy-
enhancing technologies have been developed which have proven efficiency across 
many domains including e-health. The possibility of deploying similar technologies on 
a grid infrastructure should therefore be investigated. 
5.3.4.1. Privacy-Enhancing Technologies (PETs) 
The approach to privacy typically taken by more advanced systems involves enforcing 
privacy policies at the application level; the filtering of sensitive data before providing 
the query result to the user. But this could still reveal enough information for an intelli-
gent person to identify individuals. For better protection of the data, access control 
policies have to be enforced at the data level. Traditional databases provide access con-
trol at the table level and use the view mechanism to restrict access to certain columns 
or rows of the table, but this is still inadequate. Hippocratic databases [50] provide a 
more advanced “limited disclosure” approach. They permit enforcement at a very fine 
level of granularity. Privacy policies could be enforced at the level of an individual cell 
in a relational table. Hippocratic databases also allow privacy policies to be stored and 
managed in the database as metadata. 
Sticky policies [51] have emerged as one approach to enhance privacy preservation 
in distributed computer systems. The underlying notion behind sticky policy enforce-
ment is that the policy applicable to a piece of data travels with it and is enforceable at 
each point it is used. Recent work done by the IBM Almaden Research Laboratory has 
improved this approach, making it adequate for the needs of a healthcare environment. 
They have added new functionality to handle data disclosure to a party with well-
defined constraints that allows data to be released to less privileged parties without 
requiring the originator’s involvement. A crucial task prior to the disclosure was identi-
fying the applicable privacy policy constraints for the document(s) to be shared and 
sticking them together, forming a single entity for transfer. This avoids the potential 
pitfall of having to contact a (potentially) large number of third parties before making a 
decision to disclose a specific piece of information. 
The PRIMA (PRIvacy Management Architecture [52]) System was developed by 
the IBM Almaden research lab in order to exploit policy refinement techniques to 
gradually and seamlessly embed privacy controls into clinical workflows based on the 
actual practices of the organisation in order to improve the coverage of the privacy pol-
icy. PRIMA attempts to improve policy coverage by gradually embedding new policy 
statements, which were discovered through the process of policy refinement, into the 
clinical system. Stakeholders define the privacy policies, which are embedded in pri-
vacy controls that are integrated into the clinical environment. One of these privacy 
controls is an auditing function that automatically generates entries for the system’s 
audit logs. These logs are either periodically replicated or PRIMA-enabled by the con-
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struction of a consistent, consolidated view of them. In the simplest case, there is just 
one log. At regular intervals or at the request of stakeholders, the policy refinement 
component extracts input from the audit management component and the privacy pol-
icy definition component and outputs a list of definitions, if any exist, that should be 
included in the policy definitions. 
Enterprise Privacy Authorisation Language (EPAL) [53] was designed to enable 
the translation of privacy policies into an XML based computer language. The resulting 
coded translation of human policy into information technology policy allows complex 
descriptions of the internal data handling practices needed for enforcing the privacy 
policy. The expressiveness of EPAL has been tested against a set of “real world” sce-
narios such as of the Ontario Freedom of Information and Protection of Privacy Act 
(FIPPA). This has demonstrated the effectiveness of EPAL in 
• Linking access control to natural text policies 
• Creating precise, fine grained description of the policy 
• Enabling complex, context driven conditions on policy rules 
• Creating portable, reusable policies 
• Allowing for sector/legislation specific policy vocabularies 
• Enabling policy negotiation. 
5.3.4.2. Trust-Based Technologies 
To qualify as a trustworthy system [54], the healthgrid security infrastructure needs to 
adopt technologies that are able to fulfil the following needs of users and resource pro-
viders. Before sending the job request, the user needs to:
• Know whether the resource provider host in the resource provider domain (to 
be visited) is “trustworthy” in terms of faithfully executing the user code and 
completing the task. 
• Know whether the resource provider host(s) will have enough trust in the user 
to cooperate with them (i.e. a code trust question involving trust symmetry 
problem). In many cases such a trust relationship is often implicitly assumed. 
• Ensure that the resource provider host(s) will not tamper with the user code 
and/or computation result. 
Before running the job request on the resource provider node, there can be two 
code trust questions that the resource provider node should ask: 
• Is the job requesting user trusted to produce benevolent and competent code 
that will not harm the grid? 
• Has the user program been tampered with before it is allocated? 
After completion of the job result: 
• Both user and resource provider(s) need to update their relevant trust relation-
ship knowledge. 
• The user needs to check the integrity of the completed job or result to update 
its execution trust with the resource provider(s). Resource providers need to 
update the code trust for the user. 
PETs have shown they can be efficient when deployed across a variety of domains. 
However, each technology typically only deals with a stand-alone privacy or security 
I. Andoulsi et al. / The SHARE Road Map: Healthgrids for Biomedical Research and Healthcare270
Global Healthgrid : e-Science Meets Biomedical Informatics, edited by T. Solomonides, et al., IOS Press, 2008. ProQuest Ebook
         Central, http://ebookcentral.proquest.com/lib/antwerpen/detail.action?docID=363216.

























issue. In order to optimise patient privacy protection, many PETs will need to be inte-
grated into a single privacy framework. 
The PRIME project,
3
 an EC FP6 project, aims to reconcile privacy and account-
ability of users’ electronic interactions in Europe. The project addresses these goals by 
providing an architecture integrating several privacy enhancing technologies and 
emerging systems that include human-computer interfaces, ontologies, authorization 
and cryptology, anonymous communication, privacy-enhancing identity management 
architecture, and assurance methods. The PRIME project also recognised the need for 
solutions to be compatibe with the existing legal framework in order for them to have 
real world relevance. Therefore legal requirements were considered from a very early 
stage, and the PRIME solution integrated legal rules to be more efficient and to form a 
“privacy-protecting framework that has a real impact on business practices”. 
6. Concrete Recommendations 
6.1. Technical Recommendations 
It is important that technical research and development be conducted in close collabora-
tion with user communities. At certain stages it must be driven and validated by user 
groups, although there is always scope for innovators to introduce unforeseen possibili-
ties to users. The research communities involved in the definition of the roadmap ex-
pressed their interest and support for the deployment of prototypes and test cases on 
existing grid infrastructures. We recommend that these infrastructures and tools con-
tinue to be made available to applications requiring computing services and data man-
agement.
Indeed, some projects are already using the DEISA and EGEE infrastructures for 
scientific production in the fields of epidemiology, medical imaging and drug discov-
ery. However, these initiatives come from pioneers and are not sufficient to achieve a 
wider adoption in these research communities. We recommend that: 
• More attention be paid to such initiatives so that they may influence the evolu-
tion of the technology to make it better fit the needs of the community; 
• Two projects within the framework of the EuroPhysiome initiative be identi-
fied that could directly benefit from the computing and data management re-
sources of the EGEE and DEISA infrastructures; these should be deployed in 
parallel on the two infrastructures in order to investigate interoperability is-
sues and identify bottlenecks. 
In terms of encouraging biomedical applications to fully exploit grids, we recom-
mend: 
• Linking certain advanced health domains to an e-science infrastructure; 
• The adaptation of epidemiology data sources to grid models and grid-enabled 
gateways to epidemiological data, using medical informatics-related connec-
tors such as HL7, DICOM, ENV13606, or similar. 
3
 See https://www.prime-project.eu/. 
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In the same spirit, in order to foster the uptake of grids in the biomedical research 
and healthcare communities, we recommend: 
• The release of open-source components for medical data interfacing; 
• Building a core reference database of validated experimental and clinical re-
search data extracted from the literature in innovative medicine and to explore 
whether a grid infrastructure could support this activity; 
• The creation of disease-specific European imaging networks towards the es-
tablishment of standards, validation of imaging biomarkers, development of 
regional centres of excellence in innovative medicine and exploration of grid 
infrastructures to support such activity. 
We recognise that there are a number of concerns (for example: security and stan-
dards) in which problems exist irrespective of the use of grids. It is important to under-
stand the nature of these problems and the extent to which the use of grids complicates 
them. Results could be concrete implementation recommendations (for example: secu-
rity improvement) and a suggested list of health applications requiring security which 
may be able to be deployed on a grid. In the field of standards, we believe that the 
HealthGrid initiative provides the right framework to coordinate the development of 
the different standards in collaboration with the OGF and the various medical informat-
ics standardisation bodies. We recommend: 
• The active pursuit of standards for the sharing of medical images and elec-
tronic health records on the grid within the already existing medical informat-
ics standardisation bodies; 
• The active pursuit of ontology matching and development for healthgrids; 
We believe that technology transfer between EC projects should receive more 
prominent and active encouragement. In particular, we recommend: 
• The commission implements collaboration measures in the funding mecha-
nism for projects; 
• Targeted capacity building so that projects may access grid resources on de-
mand, without previous agreement or request; European grid infrastructures 
should be freely accessible to European projects; 
• Porting of one or two biomedical grid applications, already successfully de-
ployed on grid infrastructures, to e-science environments using OGSA-
compliant grid toolkits. 
Finally, to return to a frequent theme in this analysis, we recommend: 
• The encouragement of cross community interaction, in order to build mean-
ingful dialogue between grid developers and health researchers. 
6.2. Legal Recommendations 
Liability in a healthgrid System Using grids blurs the liability issues in terms of medi-
cal practice. A stepwise approach should therefore be taken to develop the liability 
framework, distributing legal responsibility appropriately across healthgrid users. Such 
an approach would help to favour the reliance on the system while providing legal cer-
tainty for all stakeholders, including patients. Moreover, the European Commission 
should consider supporting the adoption of EU level guidelines that would identify the 
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various parties involved in delivering healthgrid services and annex services and estab-
lish the various liabilities that each party must accept. Such guidelines should be 
widely disseminated in order to develop users’ confidence in the use of healthgrids in 
general. In particular it should be investigated whether specific guidelines on those 
specific services could be drafted under the provisions for a code of conduct estab-
lished in directive 2000/31 on eCommerce [46]. 
Product safety As mentioned in D4.2, in the framework of the European level leg-
islation applicable to product safety, national authorities have been established to moni-
tor product safety and to take appropriate measures to protect consumers. Under these 
circumstances, an information system has been put in place that imposes collaboration 
between distributors, producers and the national authorities but also between member 
states and the European Commission (RAPEX) [55]. 
At present, this system is not used at all for products used in the composition of 
grid systems. The European Commission should thus adopt policy tools encouraging 
the use of the RAPEX system for such products.  
Healthgrid as a Medical Device As outlined in the introduction to this document, 
the law on medical devices is very unclear with respect to healthgrids. While it may be 
argued that a healthgrid could fall within the ambit of the current medical devices di-
rective [47] in that it is a software tool that impacts on a medical act, the whole con-
struction of the directive is based upon physical goods (which might have a software 
component) that are placed on the market for purchase or lease. In this situation, many 
of the currently available monitoring devices are covered only by general product li-
ability, but not by specific liability provision.  
In this framework, special guidelines should be issued in order to clarify the appli-
cation of medical devices legislation to specific tools used in healthgrids. 
Patient Consent In February 2007, the European working party on data protection, 
established under article 29 of the directive issued a working paper looking at the ap-
plicability of data protection legislation to Electronic Health Record (EHR) sys-
tems [48]. In its report, the working party noted in particular the limitation of the use of 
consent to permit the processing of heath data. The working party notes that if process-
ing health data in an EHR system is the primary way of processing health data in a 
given health system, then a patient’s care may be compromised if he or she opts-out of 
such a system by not giving his or her consent to the creation of an EHR. Accordingly, 
consent should not be used as it cannot be said to be truly and freely given. 
The remaining provisions setting aside the general prohibition on article 8 of the 
directive 95/46/CE [49] can also be said to pose some problems – notably the idea that 
a patient ought to know the full finality of the use of data before his or her data may 
reasonably be used. But, as noted by the data protection working party there are some 
problems in using consent as a valid basis for processing data in eHealth applications. 
Indeed, if the creation of, for example, electronic medical records is a necessary and 
unavoidable consequence of the medical situation, withholding consent may be to the 
patient’s detriment.  
Specified and Explicit Purposes According to the data protection directive [49], 
data may only be collected for specified and explicit purposes. If healthgrids can be 
used for risk detection, disease monitoring and preventive care, legal guidelines should 
be established that clarify the circumstances in which professionals can make further 
use of personal data related to health in the interests of public health. Such guidelines 
should allow for secondary uses even where such uses could not have been foreseen at 
the time of data collection.
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Technical and Organisational Security Measures Efforts should be made to har-
monise national standards on the technical and organisational measures of data security. 
While the data protection directive calls for such standards to be adopted, little has 
been done at a regulatory level to harmonise guidelines across the EU. 
Intellectual Property Rights It might be desirable for the commission to develop 
guidelines for the use of open licensing and open standards, which could address the 
tension between the intellectual property rights of developers and the needs of the grid 
technology. Such an open standards software approach could then be a solution to help 
the development and implementation of healthgrids. 
On the other hand, the use of healthgrids in the drug discovery sector raises the is-
sue of the ownership of both methods used to discover the medicines and the results 
achieved. Indeed, all the grid nodes that contribute resources to compute the docking 
probabilities could claim some ownership of the results and the designers of the soft-
ware used in the process would certainly be in position to claim ownership of the 
method. In this context, one may ask whether it is important to know, say, which grid 
node was the one to identify a particular candidate molecule. 
In this context, it is of essential interest, notably in patents, to determine guidelines 
that would determine, in case of collaboration in the research, what every actor is enti-
tled to according to his contribution to the system. 
Privacy Policies and Codes of Conduct As suggested above, a directive or code of 
conduct on privacy and health information infrastructure should be developed within 
the context of directive 95/46/EC and could take the form of either a dedicated direc-
tive or could be an EU-level code of conduct to be approved by the European working 
party on data protection set up under article 29 of the directive. This could help to solve 
the problem of data processing legitimacy. In particular, it could provide possible bases 
of legitimacy other than the data subject’s consent. It could also provide the following 
solutions: 
• Appropriate safeguards to allow for the further processing of personal data 
(and especially of medical data) for substantial public interests (without re-
quiring the data subject’s consent) like scientific research. An example of ap-
propriate safeguard would be a first coding by the initial data controller and a 
second coding by a trusted third party gathering all the data from the data con-
trollers before sending them to the researchers. 
• Appropriate safeguards to allow keeping the data for longer periods for scien-
tific use; terms under which identification numbers or other identifiers may be 
used; terms under which (coded) personal data may be transferred to third 
countries for scientific research. 
6.3. Socio-Economic Recommendations 
Trust and Acceptance Trust is a very important element in any interaction between the 
different members of a society. In the market context, trust is crucial for successful 
business to business collaborations. Similarly, in a healthgrid domain a good collabora-
tion will not be achieved unless a trust relationship exists between the different users 
and stakeholders. Pilot projects and prototype applications, which are an inherent part 
of the technology roadmap, need to be future oriented in the sense that the ultimate 
routine operation users have to be persuaded both of their value and their applicability, 
i.e. their ability to fit into real clinical or research workflows. This has to be taken seri-
I. Andoulsi et al. / The SHARE Road Map: Healthgrids for Biomedical Research and Healthcare274
Global Healthgrid : e-Science Meets Biomedical Informatics, edited by T. Solomonides, et al., IOS Press, 2008. ProQuest Ebook
         Central, http://ebookcentral.proquest.com/lib/antwerpen/detail.action?docID=363216.

























ously from the very beginning, even in proof-of-technology demonstrators: the goal 
should always be to give users, especially clinicians, tools that they would consider 
using with patients in real healthcare situations. Trust and acceptance can be greatly 
enhanced by the establishment of appropriate ethics committee structures to advise on 
the observance of ethical principles. 
Estimation of Costs and Benefits Ex-ante analyses over time, based on initial pilot 
experience, have to focus on ensuring acceptance, technical and regulatory certainty, 
and sufficient private incentives in the steps to follow. An inherent part of such assess-
ments should be to estimate potential net benefits (i.e. expected benefits less expected 
costs over time), accounting for different risks and for optimism bias in estimations. 
Such studies will facilitate access to initial funding, but can also be beneficial in the 
necessary dissemination work among the health sector. 
Sustainability Guarantees Work towards achieving the next milestone in com-
plexity – data grids – will benefit from more focused prospective assessments of socio-
economic impact in order to a) identify already existing, as well as potential barriers, 
and b) build convincing business cases ensuring sustainability. The analysis of alterna-
tive resource allocation options from a societal perspective, but also on organisational 
level, becomes necessary. 
An organisational milestone can be defined here in the move from technology sci-
ence towards service provision. By that stage, a notable amount of legal and regulatory 
certainty has to be achieved, so that private incentives can be assessed and adjusted 
(including via government intervention) if necessary. 
Cross-Organisational Interoperability The effective deployment of knowledge 
grids will crucially depend on collaboration between institutions, meaning more than 
“simple” access to each others’ data and computing resources. This collaboration re-
quires the utilisation of human resources and in some cases a significant strategic re-
orientation and re-organisation of working processes and even management structures. 
As the health sector, including clinical research and public health, is (and should be) 
highly regulated, policy makers on regional, national, and EU level should review the 
existing regulatory framework against the requirements arising from the exploitation of 
knowledge grids. Particular attention should be given to flexibility of government regu-
lated budgets and reimbursement schemes. The latter should encourage cross-
organisational collaboration, including such beyond national borders, by means of us-
ing knowledge grids. 
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8. Terminology 
8.1. Abbreviations 
DICOM The Digital Imaging and Communications in Medicine Standard 
EC European Commission 
EHR Electronic Health Record 
ELSE Ethical, Legal and Socio-Economic 
EPAL Enterprise Privacy Authorization Language 
EU European Union
HL7 The Health Level 7 Standard 
HPC High Performance Computing 
IPR Intellectual Property Rights 
OGSA Open Grid Services Architecture 
QoS Quality of Service 
SHARE Supporting and structuring Healthgrid Activities and Research in Europe 
SOKU Service Oriented Knowledge Utility 
VPH Virtual Physiological Human 
W3C World Wide Web Consortium 
WPx Work Package x 
WP3 SHARE Technology and Security Activity 
WP4 SHARE Health Policy, Legal, Social and Economics Activity 
WP5 SHARE Applications Activity 
WP6 SHARE Roadmap Synthesis and Validation Activity 
8.2. Definitions 
The following definitions are useful for understanding the document content. 
• Authentication: Verifying and confirming the identity of a grid user. 
• Authorisation: Restricting access to resources based on what a user has been 
granted access to. 
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• Data: Any and all complex data entities from observations, experiments, 
simulations, models, and higher order assemblies, along with the associated 
documentation needed to describe and interpret them. 
• Data controller: The person or organisation responsible for the manner in 
which any personal data is processed. 
• Data mining: Automatically searching large volumes of data for patterns or 
associations. 
• Data model: A model that describes in an abstract way how data is repre-
sented in an information system. A data model can be a part of ontology, 
which is a description of how data is represented in an entire domain. 
• Data processor: Any person who processes data on behalf of a data controller. 
• Data subject: An individual who is the subject of personal data. 
• Grid: A fully distributed, dynamically reconfigurable, scalable and autono-
mous infrastructure to provide location independent, pervasive, reliable, se-
cure and efficient access to a coordinated set of services encapsulating and 
virtualising resources. 
• Informed consent: A legal term referring to a situation where a person can be 
said to have given their consent based upon an appreciation and understanding 
of the facts and implications of an action. 
• Metadata: May be regarded as a subset of data, and are data about data. 
Metadata summarise data content, context, structure, inter-relationships, and 
provenance (information on history and origins). They add relevance and pur-
pose to data, and enable the identification of similar data in different data col-
lections.
• Middleware: A software stack composed of security, resource management, 
data access, accounting, and other services required for applications, users, 
and resource providers to operate effectively in a grid environment. 
• Ontology: The systematic description of a given phenomenon, which often 
includes a controlled vocabulary and relationships, captures nuances in mean-
ing and enables knowledge sharing and reuse. Typically, ontology defines 
data entities, data attributes, relations and possible functions and operations. 
• Processing: Obtaining, recording or holding the data, or carrying out any op-
eration on the data, including organising, adapting or altering it. Retrieval, 
consultation or use of the data, disclosure of the data, and alignment, combi-
nation, blocking, erasure or destruction of the data are all legally classed as 
processing. 
• Roadmapping: An extended look at the future of a chosen field of inquiry, 
leading to an outline or map of how and by what means to achieve certain 
goals. 
• SOAP: A protocol for exchanging XML messages over a network. It defines 
the structure of the XML messages (the SOAP envelope), and a framework 
that defines how these messages should be processed by software. 
• The Article 29 Data Protection Working Party: A working party estab-
lished by article 29 of directive 95/46/EC. It is the independent EU advisory 
body on data protection and privacy. Its tasks are laid down in article 30 of di-
rective 95/46/EC and in article 14 of directive 97/66/EC. 
• Virtual Organisation: A group of grid users with similar interests and re-
quirements working collaboratively and/or sharing resources regardless of 
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• Web Service: A software system designed to allow inter-computer interaction 
over a network to perform a task. Other computers interact with a web service, 
in a manner prescribed by its interface, using messages which are enclosed in 
a SOAP envelope and are often conveyed by HTTP. Software applications 
can use web services to exchange data over a network. 
• Workflow: A set of components and relations between them, used to define a 
complex process from simple building blocks. Relations may be in the form of 
data links which allow the output of one component to be used as the input of 
another, or control links which state some conditions on the execution of a 
component. 
• XML: An annotation technology used to describe structured data within a 
document using mark-ups and tags, similar to HTML. The main difference be-
tween the two is that the elements in XML can be given a definition depend-
ing on their usage which may be semantic rather than presentational. XML is 
a text format and can be read easily either by humans or machines. 
• XML Schema: A definition of the structure of an XML document. A schema 
contains a set of rules that dictate how an XML document must look like in 
order to be an instance of this schema. The relationship between a schema and 
an XML document implementing it can be compared with a class definition 
and an instance in object-oriented programming. 
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